227 related articles for article (PubMed ID: 15521935)
1. Blood loss and transfusion after total mesorectal excision and conventional rectal cancer surgery.
Mynster T; Nielsen HJ; Harling H; Bülow S;
Colorectal Dis; 2004 Nov; 6(6):452-7. PubMed ID: 15521935
[TBL] [Abstract][Full Text] [Related]
2. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.
Kapiteijn E; Putter H; van de Velde CJ;
Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680
[TBL] [Abstract][Full Text] [Related]
3. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
[TBL] [Abstract][Full Text] [Related]
4. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients.
Law WL; Chu KW
Ann Surg; 2004 Aug; 240(2):260-8. PubMed ID: 15273550
[TBL] [Abstract][Full Text] [Related]
5. Results after change of treatment policy for rectal cancer--report from a single hospital in China.
Wu AW; Gu J; Wang J; Ye SW; An Q; Yao YF; Zhan TC
Eur J Surg Oncol; 2007 Aug; 33(6):718-23. PubMed ID: 17240113
[TBL] [Abstract][Full Text] [Related]
6. [Effect of total mesorectal excision and preoperative chemoradiotherapy on local recurrence in rectal cancer].
Wu AW; Gu J; Wang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):207-9. PubMed ID: 16721678
[TBL] [Abstract][Full Text] [Related]
7. [Recurrence and survival after conventional low anterior resection for rectal cancer].
Bülow S; Moesgaard FA; Crone PO; Gandrup P; Holm J; Kronborg O; Hemmert-Lund H; Myrhøj T; Petersen RH; Qvist N; Raskov HH; Thomsen H
Ugeskr Laeger; 2001 Jul; 163(27):3793-7. PubMed ID: 11466988
[TBL] [Abstract][Full Text] [Related]
8. The impact of total mesorectal excision in middle and low rectal carcinomas.
Tentes AA; Korakianitis OS; Veliovic D; Sgouridou E; Karagiozoglou C; Moustakas K
J BUON; 2010; 15(1):56-60. PubMed ID: 20414928
[TBL] [Abstract][Full Text] [Related]
9. Operative blood loss and use of blood products after laparoscopic and conventional open colorectal operations.
Kiran RP; Delaney CP; Senagore AJ; Millward BL; Fazio VW
Arch Surg; 2004 Jan; 139(1):39-42. PubMed ID: 14718273
[TBL] [Abstract][Full Text] [Related]
10. [Total mesorectal excision versus conventional radical surgery for rectal cancer: a meta analysis].
Liang YC; Qing SH; Ding WX; Chen PY; Huang YB; Yu HT
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):43-8. PubMed ID: 17253173
[TBL] [Abstract][Full Text] [Related]
11. Total mesorectal excision with the water-jet-dissection. Technique and results.
Köckerling F; Yildirim C; Rose J; Scheidbach H; Geers P
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s217-25. PubMed ID: 15655628
[TBL] [Abstract][Full Text] [Related]
12. Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention.
De Graaf EJ; Doornebosch PG; Tollenaar RA; Meershoek-Klein Kranenbarg E; de Boer AC; Bekkering FC; van de Velde CJ
Eur J Surg Oncol; 2009 Dec; 35(12):1280-5. PubMed ID: 19487099
[TBL] [Abstract][Full Text] [Related]
13. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
[TBL] [Abstract][Full Text] [Related]
14. The surgical approach to locally recurrent rectal cancer.
Spiliotis J; Datsis A
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s33-5. PubMed ID: 15655636
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic versus open total mesorectal excision: a comparative study on short-term outcomes. A single-institution experience regarding anterior resections and abdominoperineal resections.
Veenhof AA; Engel AF; Craanen ME; Meijer S; de Lange-de Klerk ES; van der Peet DL; Meijerink WJ; Cuesta MA
Dig Surg; 2007; 24(5):367-74. PubMed ID: 17785982
[TBL] [Abstract][Full Text] [Related]
16. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer.
Martling A; Cedermark B; Johansson H; Rutqvist LE; Holm T
Br J Surg; 2002 Aug; 89(8):1008-13. PubMed ID: 12153626
[TBL] [Abstract][Full Text] [Related]
17. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam.
Visser O; Bakx R; Zoetmulder FA; Levering CC; Meijer S; Slors JF; van Lanschot JJ
J Surg Oncol; 2007 May; 95(6):447-54. PubMed ID: 17048237
[TBL] [Abstract][Full Text] [Related]
18. Audit of intraoperative and early postoperative complications after introduction of mesorectal excision for rectal cancer.
Nesbakken A; Nygaard K; Westerheim O; Lunde OC; Mala T
Eur J Surg; 2002; 168(4):229-35. PubMed ID: 12440761
[TBL] [Abstract][Full Text] [Related]
19. Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery.
Maurer CA; Z'Graggen K; Renzulli P; Schilling MK; Netzer P; Büchler MW
Br J Surg; 2001 Nov; 88(11):1501-5. PubMed ID: 11683749
[TBL] [Abstract][Full Text] [Related]
20. Survival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery.
Rutten H; den Dulk M; Lemmens V; Nieuwenhuijzen G; Krijnen P; Jansen-Landheer M; van de Poll Franse L; Coebergh JW; Martijn H; Marijnen C; van de Velde C
Eur J Cancer; 2007 Oct; 43(15):2295-300. PubMed ID: 17709242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
